Neoplastic Syndromes, Hereditary
Welcome,         Profile    Billing    Logout  
 44 Companies   52 Products   52 Products   63 Mechanisms of Action   2 Trials   315 News 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Neoplastic Syndromes, Hereditary
NCT00652990: Sirolimus to Treat Plexiform Neurofibromas in Patients With Neurofibromatosis Type I

Active, not recruiting
2
18
US
Sirolimus
University of Alabama at Birmingham, National Cancer Institute (NCI)
Neurofibromatosis Type 1, Plexiform Neurofibromas, Paraspinal Plexiform Neurofibromas
08/14
08/14
NCT02258243: Photodynamic Therapy Using Blue Light or Red Light in Treating Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome

Active, not recruiting
2
3
US
aminolevulinic acid hydrochloride, 5-ALA HCl, ALA HCl, aminolevulinic acid HCl, photodynamic therapy, Light Infusion Therapy™, PDT, therapy, photodynamic, laboratory biomarker analysis, questionnaire administration
Case Comprehensive Cancer Center, National Cancer Institute (NCI)
Basal Cell Carcinoma of the Skin, Nevoid Basal Cell Carcinoma Syndrome
10/16
12/17
NCT01199250: Biomarkers in Samples From Patients With Endometrial Cancer

Withdrawn
N/A
3600
US
Laboratory Biomarker Analysis
Gynecologic Oncology Group, National Cancer Institute (NCI)
Lynch Syndrome, Recurrent Uterine Corpus Carcinoma, Stage I Uterine Corpus Cancer, Stage II Uterine Corpus Cancer, Stage III Uterine Corpus Cancer, Stage IV Uterine Corpus Cancer
05/19
05/19
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Neoplastic Syndromes, Hereditary
NCT00652990: Sirolimus to Treat Plexiform Neurofibromas in Patients With Neurofibromatosis Type I

Active, not recruiting
2
18
US
Sirolimus
University of Alabama at Birmingham, National Cancer Institute (NCI)
Neurofibromatosis Type 1, Plexiform Neurofibromas, Paraspinal Plexiform Neurofibromas
08/14
08/14
NCT02258243: Photodynamic Therapy Using Blue Light or Red Light in Treating Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome

Active, not recruiting
2
3
US
aminolevulinic acid hydrochloride, 5-ALA HCl, ALA HCl, aminolevulinic acid HCl, photodynamic therapy, Light Infusion Therapy™, PDT, therapy, photodynamic, laboratory biomarker analysis, questionnaire administration
Case Comprehensive Cancer Center, National Cancer Institute (NCI)
Basal Cell Carcinoma of the Skin, Nevoid Basal Cell Carcinoma Syndrome
10/16
12/17
NCT01199250: Biomarkers in Samples From Patients With Endometrial Cancer

Withdrawn
N/A
3600
US
Laboratory Biomarker Analysis
Gynecologic Oncology Group, National Cancer Institute (NCI)
Lynch Syndrome, Recurrent Uterine Corpus Carcinoma, Stage I Uterine Corpus Cancer, Stage II Uterine Corpus Cancer, Stage III Uterine Corpus Cancer, Stage IV Uterine Corpus Cancer
05/19
05/19

Download Options